Printer Friendly

BOSTON SCIENTIFIC CORPORATION ANNOUNCES ACQUISITION OF DATASCOPE CORONARY ANGIOPLASTY PRODUCT LINE

 WATERTOWN, Mass., June 8 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) announced that it has acquired from Datascope Corp. its coronary angioplasty product line. The acquisition will provide Boston Scientific an entry to the fixed wire segment of the PTCA balloon market.
 The acquisition includes the Integra I, Integra II (fixed wire catheters); Silhouette, Micross-SL (over the wire catheters); Turbo Support exchange catheter; and the Slidewire .014" Interlock Extension Wire products. Boston Scientific will manufacture and distribute these products worldwide.
 Pete Nicholas, co-chairman and chief executive officer said, "The acquisition of the Datascope PTCA technology advances the timetable for our Mansfield Division to offer a full PTCA product line. It will strengthen the company's competitive position in this important market."
 Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices. The company's products are used in a broad range of interventional medical specialties including cardiology, gastroenterology, pulmonary medicine, radiology, urology, and vascular surgery.
 -0- 6/8/93
 /CONTACT: Larry Best of Boston Scientific Corporation, 617-972-4450/
 (BSX)


CO: Boston Scientific Corporation ST: Massachusetts IN: MTC SU: TNM

CM -- NE016 -- 4415 06/08/93 16:02 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jun 8, 1993
Words:186
Previous Article:STRACZYNSKI NAMED PRESIDENT OF OF CITIZENS BANK OF MASSACHUSETTS
Next Article:COPLEY PHARMACEUTICAL ANNOUNCES THE APPROVAL OF HEPTALAC (LACTULOSE SOLUTION USP), 10G/15ML AND EVALOSE (LACTULOSE SOLUTION USP), 10G/15ML
Topics:


Related Articles
NAMIC U.S.A. AGREEMENT WITH NOVOSTE PUERTO RICO
DATASCOPE TO SUSPEND ANGIOPLASTY OPERATIONS
DATASCOPE CORP. REPORTS SALE OF ANGIOPLASTY BUSINESS
DEVELOPMENT OF ULTRASOUND IMAGING TECHNOLOGY TO ACCELERATE AS BOSTON SCIENTIFIC CORPORATION AND CARDIOVASCULAR IMAGING SYSTEMS AGREE TO MERGE
DATASCOPE RECEIVES APPROVABLE LETTER FOR VASOSEAL FROM FDA
DATASCOPE LAUNCHES VASOSEAL AT AHA
United States Surgical Corporation Enters Into An Agreement For Interventional Cardiology Products
Boston Scientific Corporation Announces Agreement To Acquire Schneider
AVE Announces Closing of Acquisition of Bard's Coronary Cath Lab Business.
Boston Scientific Announces Completion of Interventional Technologies, Inc. Acquisition.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters